Enantios–SEVERAL: investment, 202407 seed financing round >CHF1.8m led by Privilège Ventures

	Period	2024-07-01
	Money taker	SEVERAL
	Product	analytical chemistry
	Product 2	venture capital

Venture Kick. (7/1/24). "Press Release: ETH Zurich Spin-off Enantios Secures Over CHF 1.8M in Seed Funding to Innovate Complex Molecule Characterization".

The innovative deeptech company Enantios, originating from ETH Zurich, has successfully raised over CHF 1.8 million in Seed funding. The financial boost will advance its technology, support hiring, and strengthen partnerships, positioning Enantios as a leader in scientific innovation.

[photo] Enantios Co-Founders: CTO Roman Wyss and CEO Carin Lightner

Enantios, an ETH Zurich deeptech spin-off announced it raised over 1.8 million CHF for its new molecule characterization method. Enantios technology, developed over a five-year research project at ETH Zurich, enables the complete characterization of complex molecules and aspects of the three-dimensional structure which are not possible to resolve with other methods.

Privilège Ventures led this funding round with additional capital from Zürcher Kantonalbank (ZKB) and several Family Offices and private investors.

Enantios is bringing to market a new innovative approach to molecular characterization which addresses critical bottlenecks in traditional drug development. The company plans to allocate the seed round funding towards several key initiatives, including technology development, talent acquisition, and strategic partnerships with pharmaceutical companies, academic institutions, and research organizations.

Enantios won the second stage of Venture Kick in 2023.

"The support from Venture Kick phase I and II came at a crucial time for our team and company and this early-stage support allowed us to continue moving forward and grow while also hitting key product development milestones," commented Carin Lightner, Co-Founder and CEO of Enantios. "In addition to the financial support, the feedback from the Venture Kick jury in the kickers camps really helped us strengthen our messaging and our resolve to build the best company and product possible".

Record changed: 2024-07-31

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Enantios AG

[1] Venture Kick. (7/1/24). "Press Release: ETH Zurich Spin-off Enantios Secures Over CHF 1.8M in Seed Funding to Innovate Complex Molecule Characterization"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com